List of Tables
Table 1: India Generic Drugs Size, By Product Type, By Value, 2018-2028
Table 2: India Generic Drugs Market Size, By Route of Administration, By Value, 2018-2028
Table 3: India Generic Drugs Market Size, By Application, By Value, 2018-2028
Table 4: India Generic Drugs Market Size, By Distribution Channel, By Value, 2018-2028
Table 5: Teva Pharmaceutical Industries Business Overview
Table 6: Teva Pharmaceutical Industries Financial Analysis
Table 7: Wockhardt Pharmaceutical Business Overview
Table 8: Wockhardt Pharmaceutical Financial Analysis
Table 9: Sandoz, A Novartis division Business Overview
Table 10: Sandoz, A Novartis division Financial Overview
Table 11: Fresenius Kabi Business Overview
Table 12: Fresenius Kabi Financial Overview
Table 13: Aurobindo Pharma Business Overview
Table 14: Aurobindo Pharma Financial Overview
Table 15: Sun Pharma Business Overview
Table 16: Sun Pharma Financial Analysis
Table 17: Dr. Reddy Business Overview
Table 18: Dr. Reddy Financial Analysis
Table 19: Lupin Business Overview
Table 20: Lupin Financial Overview
Table 21: Cipla Business Overview
Table 22: Cipla Financial Overview
Table 23: Viatris Business Overview
Table 24: Viatris Financial Overview

LIST OF FIGURE

List of Figures
Fig 1: India Generic Drugs Segmentation
Fig 2: India Generic Drugs Market Value Chain Analysis
Fig 3: India Generic Drugs Market Size, By Value (USD Million), 2018-2028
Fig 4: India Generic Drugs Market Share, By Product Type, By Value, 2018-2028
Fig 5: India Generic Drugs Market Share, By Route of Administration, By Value, 2018-2028
Fig 6: India Generic Drugs Market Share, By Application, By Value, 2018-2028
Fig 7: India Generic Drugs Market Share, By Distribution Channel, By Value, 2018-2028
Fig 8: Company Share Analysis, 2021